Understanding how a specific receptor interacts with a virus that causes serious illness.
LDLRAD3 Receptor Interaction with Venezuelan Equine Encephalitis Virus
This study is looking at how a specific receptor in our cells helps the Venezuelan equine encephalitis virus get inside, which could help us find new ways to treat or prevent infections caused by this virus, especially for those at risk of serious illness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10867410 on NIH RePORTER |
What this research studies
This research investigates the interaction between the LDLRAD3 receptor and the Venezuelan equine encephalitis virus (VEEV), which is transmitted by mosquitoes and can lead to severe neurological diseases. Using advanced CRISPR technology, the researchers aim to uncover how this receptor facilitates the virus's entry into human cells. By studying the genetic and structural aspects of this interaction, the project seeks to provide insights into the mechanisms of infection and disease progression. The findings could pave the way for developing targeted antiviral therapies or vaccines against alphavirus infections.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals at risk of infection from Venezuelan equine encephalitis virus, particularly those living in or traveling to endemic regions.
Not a fit: Patients who are not at risk of alphavirus infections or those with existing antiviral treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective antiviral treatments or vaccines for alphavirus infections, significantly improving patient outcomes.
How similar studies have performed: Other research has shown promise in using CRISPR technology to understand viral interactions, indicating that this approach could yield valuable insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Diamond, Michael S — Washington University
- Study coordinator: Diamond, Michael S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.